Skip to content

Pharmacokinetics of Melatonin Administered in Oral, Lotion, and Bubble Bath Formulations

Pharmacokinetics of Melatonin Administered in Oral, Lotion, and Bubble Bath Formulations

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06382610
Enrollment
12
Registered
2024-04-24
Start date
2024-05-19
Completion date
2026-07-31
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Keywords

melatonin, transdermal, oral, pharmacokinetics

Brief summary

Melatonin is a hormone that promotes sleep that is available without a prescription in the United States. In addition to oral supplements, melatonin can be purchased in the form of lotions and bubble baths with unknown dosage and no frequency or age recommendations. In this study, researchers will examine how quickly melatonin in lotion and bubble bath is absorbed compared to oral tablets, as well as how long the melatonin lasts in the body.

Detailed description

Melatonin is a hormone that promotes sleep that is available without a prescription in the United States. In addition to oral supplements, melatonin can be purchased in the form of lotions and bubble baths with unknown dosage and no frequency or age recommendations. A previous study (unpublished) has shown that a small amount of an over-the-counter lotion increases salivary melatonin levels by up to 1000 fold, a startling amount. Researchers will characterize the time course of the absorption and metabolism of lotion- and bubble bath-based melatonin compared to oral tablets in healthy 18-21 year olds. The peak level, time to peak level and half-life of melatonin will be compared between the administration routes using a within-person (repeated measures) design and saliva sampling over 48 hours. Participants can choose specific days to participate within a one-month window, with a maximum of four sampling periods. All participants will collect control saliva samples (no melatonin treatment) one night at 10 PM and 4 AM. Participants will be asked to have two treatments 1) oral melatonin and 2) either lotion melatonin or bubble-bath melatonin. Participants can indicate if they have a preference for lotion vs. bubble bath or if they are willing to undergo both lotion and bubble bath treatments (adding a fourth sampling period). Order will be randomized. For the treatments, saliva sampling times are as follows: Prior to melatonin administration (10 AM), then 15 min, 30 min, 45 min, 60 min, 90 min, 2 hours, 3 hours, 4 hours, 6 hours, 8 hours, 12 hours (10 PM), 18 hours (4 AM), 24 hours, 36 hours, and 48 hours after administration. Samples will be frozen at the participant's home until returned to the researchers at a later date. Melatonin in saliva samples will be quantitated via Enzyme Linked Immunosorbent Assay.

Interventions

DIETARY_SUPPLEMENTMelatonin

Melatonin will be administered in three different forms

Sponsors

University of Redlands
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Repeated measures crossover trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 21 Years
Healthy volunteers
Yes

Inclusion criteria

* University of Redlands student

Exclusion criteria

* Allergies or sensitivities to scented lotions or bath products * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Salivary melatonin levelfrom immediately prior to administration to 48 hours post administrationassessed via ELISA

Secondary

MeasureTime frameDescription
Side effectsfrom immediately prior to administration to 48 hours post administrationFrequency of headache, drowsiness, dizziness, skin irritation, vivid dreams, and nightmares

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLisa E Olson, Ph.D.

University of Redlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026